Freedonia Focus on Transdermal & Implantable Drug Delivery Systems

/Home/Biologics Delivery - Protein Synthesis/Biologics Market Research - Protein Synthesis

Freedonia Focus on Transdermal & Implantable Drug Delivery Systems
Freedonia Focus
July 1, 2006
19 Pages
Pub ID: FFO1316657
US $500.00 Online Download
Abstract
This report discusses US transdermal and implantable drug delivery systems for the years 2000 and 2005, with forecasts to 2010. Topics covered include market size, product and end-use segmentation, technology and product development, market environment, product and end-use forecasts, industry composition and leading participants. Product segments cover transdermal systems (including pain control agents, hormones and related agents, cardiovascular agents, and other transdermal systems) and implantable systems (including drug-eluting stents and other implantable systems). End-use applications include central nervous system agents, cardiovascular agents, hormones and related agents, and anticancer and other agents. This 19 page report also includes a highlights summary and resources section.